WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Ceribell clears three EEG algorithms under K261712 with no age limit Oura shelves its $2.2B Nasdaq IPO four weeks after filing VCD Medical clears VEnice, a clip that closes varicose veins without heat Sofinnova closes an 82 million euro fund to start six to eight device companies Nyxoah hires former Teleflex CEO Liam Kelly to run the Genio US launch SI-BONE clears Granite Onyx, its first compromised bone implant outside the pelvis Route 92 Medical clears the FreeClimb 46, the smallest catheter in its stroke line Insera clears the CLEAR aspiration system for peripheral clot removal under K253404 Webster Equity takes Lifecore Biomedical private at $6.28 a share plus CVRs Ceribell clears three EEG algorithms under K261712 with no age limit Oura shelves its $2.2B Nasdaq IPO four weeks after filing VCD Medical clears VEnice, a clip that closes varicose veins without heat Sofinnova closes an 82 million euro fund to start six to eight device companies Nyxoah hires former Teleflex CEO Liam Kelly to run the Genio US launch SI-BONE clears Granite Onyx, its first compromised bone implant outside the pelvis Route 92 Medical clears the FreeClimb 46, the smallest catheter in its stroke line Insera clears the CLEAR aspiration system for peripheral clot removal under K253404 Webster Equity takes Lifecore Biomedical private at $6.28 a share plus CVRs

Fund close

Sofinnova closes an 82 million euro fund to start six to eight device companies

MedDevice Startups Staff · 1 day ago · 2 min read · Via MedTech Dive

Sofinnova Partners closed Sofinnova MD Start IV at 82 million euros, about $93 million, on September 29. The fund creates companies rather than investing in ones that already exist, and Sofinnova expects six to eight medtech ventures out of it over five years across Europe and the US.

The prior vehicle, MD Start III, closed at 63 million euros and seeded six companies that raised more than 140 million euros in follow-on rounds. Partners Anne Osdoit, Cecile Dupont and Mano Iyer run the strategy, with Gerard Hascoet and Josh Makower as venture partners.

For an engineer or clinician holding a concept and no entity, an incubation fund is not the same pitch as a Series A. The deal usually trades a larger equity share for the fund doing the company formation, the early regulatory strategy and the first hires.

Questions & Answers

How much did Sofinnova MD Start IV raise?

Sofinnova Partners closed Sofinnova MD Start IV at 82 million euros, about $93 million, announced September 29, 2026.

How many companies will Sofinnova MD Start IV create?

Sofinnova expects MD Start IV to launch six to eight new medtech ventures over the next five years, across Europe and the United States.

How did the previous Sofinnova MD Start fund perform?

Sofinnova MD Start III closed at 63 million euros and seeded six companies, which went on to raise more than 140 million euros in follow-on funding.

← Back to Fundraising